1250 related articles for article (PubMed ID: 19033927)
1. Immunohistochemical expression of D2-40 in benign and malignant sebaceous tumors and comparison to basal and squamous cell carcinomas.
Yang HM; Cabral E; Dadras SS; Cassarino DS
Am J Dermatopathol; 2008 Dec; 30(6):549-54. PubMed ID: 19033927
[TBL] [Abstract][Full Text] [Related]
2. Immunolabeling pattern of cytokeratin 19 expression may distinguish sebaceous tumors from basal cell carcinomas.
Heyl J; Mehregan D
J Cutan Pathol; 2008 Jan; 35(1):40-5. PubMed ID: 18095993
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemistry in ocular carcinomas.
Sramek B; Lisle A; Loy T
J Cutan Pathol; 2008 Jul; 35(7):641-6. PubMed ID: 18201230
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of survivin in cutaneous sebaceous lesions.
Calder KB; Khalil FK; Schlauder S; Cualing HD; Morgan MB
Am J Dermatopathol; 2008 Dec; 30(6):545-8. PubMed ID: 19033926
[TBL] [Abstract][Full Text] [Related]
5. Distinction of benign sebaceous proliferations from sebaceous carcinomas by immunohistochemistry.
Cabral ES; Auerbach A; Killian JK; Barrett TL; Cassarino DS
Am J Dermatopathol; 2006 Dec; 28(6):465-71. PubMed ID: 17122489
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical findings of sebaceous carcinoma and sebaceoma: retrieval of cytokeratin expression by a panel of anti-cytokeratin monoclonal antibodies.
Ansai S; Arase S; Kawana S; Kimura T
J Dermatol; 2011 Oct; 38(10):951-8. PubMed ID: 21592202
[TBL] [Abstract][Full Text] [Related]
7. Immunolabeling pattern of podoplanin (d2-40) may distinguish basal cell carcinomas from trichoepitheliomas: a clinicopathologic and immunohistochemical study of 49 cases.
Plaza JA; Ortega PF; Bengana C; Stockman DL; Suster S
Am J Dermatopathol; 2010 Oct; 32(7):683-7. PubMed ID: 20559122
[TBL] [Abstract][Full Text] [Related]
8. Cytokeratin 15 expression in neoplasms with sebaceous differentiation.
Misago N; Narisawa Y
J Cutan Pathol; 2006 Sep; 33(9):634-41. PubMed ID: 16965339
[TBL] [Abstract][Full Text] [Related]
9. Characteristic Ber-EP4 and EMA expression in sebaceoma is immunohistochemically distinct from basal cell carcinoma.
Fan YS; Carr RA; Sanders DS; Smith AP; Lazar AJ; Calonje E
Histopathology; 2007 Jul; 51(1):80-6. PubMed ID: 17593083
[TBL] [Abstract][Full Text] [Related]
10. Podoplanin is a highly sensitive and specific marker to distinguish primary skin adnexal carcinomas from adenocarcinomas metastatic to skin.
Liang H; Wu H; Giorgadze TA; Sariya D; Bellucci KS; Veerappan R; Liegl B; Acs G; Elenitsas R; Shukla S; Youngberg GA; Coogan PS; Pasha T; Zhang PJ; Xu X
Am J Surg Pathol; 2007 Feb; 31(2):304-10. PubMed ID: 17255777
[TBL] [Abstract][Full Text] [Related]
11. Comparative examination of androgen receptor reactivity for differential diagnosis of sebaceous carcinoma from squamous cell and basal cell carcinoma.
Asadi-Amoli F; Khoshnevis F; Haeri H; Jahanzad I; Pazira R; Shahsiah R
Am J Clin Pathol; 2010 Jul; 134(1):22-6. PubMed ID: 20551262
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous immunoreactivity of D2-40 antibody beyond the lymphatics.
Gomaa AH; Yaar M; Bhawan J
Am J Dermatopathol; 2007 Feb; 29(1):18-21. PubMed ID: 17284957
[TBL] [Abstract][Full Text] [Related]
13. Value of p63 and podoplanin (D2-40) immunoreactivity in the distinction between primary cutaneous tumors and adenocarcinomas metastatic to the skin: a clinicopathologic and immunohistochemical study of 79 cases.
Plaza JA; Ortega PF; Stockman DL; Suster S
J Cutan Pathol; 2010 Apr; 37(4):403-10. PubMed ID: 20377670
[TBL] [Abstract][Full Text] [Related]
14. Lipid synthesis and processing proteins ABHD5, PGRMC1 and squalene synthase can serve as novel immunohistochemical markers for sebaceous neoplasms and differentiate sebaceous carcinoma from sebaceoma and basal cell carcinoma with clear cell features.
Chen WS; Chen PL; Li J; Lind AC; Lu D
J Cutan Pathol; 2013 Jul; 40(7):631-8. PubMed ID: 23557589
[TBL] [Abstract][Full Text] [Related]
15. The diagnostic use of low molecular weight keratin expression in sebaceous carcinoma.
Murata T; Nakashima Y; Takeuchi M; Sueishi K; Inomata H
Pathol Res Pract; 1993 Sep; 189(8):888-93. PubMed ID: 7508102
[TBL] [Abstract][Full Text] [Related]
16. Sebaceous carcinoma: an immunohistochemical reappraisal.
Ansai S; Takeichi H; Arase S; Kawana S; Kimura T
Am J Dermatopathol; 2011 Aug; 33(6):579-87. PubMed ID: 21778832
[TBL] [Abstract][Full Text] [Related]
17. Sebaceoma of the external ear canal: an unusual location. Case report and review of the literature.
El Demellawy D; Escott N; Salama S; Alowami S
J Cutan Pathol; 2008 Oct; 35(10):963-6. PubMed ID: 18564279
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical staining for androgen receptors: a sensitive marker of sebaceous differentiation.
Bayer-Garner IB; Givens V; Smoller B
Am J Dermatopathol; 1999 Oct; 21(5):426-31. PubMed ID: 10535570
[TBL] [Abstract][Full Text] [Related]
19. Androgen receptor identification in the diagnosis of eyelid sebaceous carcinomas.
Jakobiec FA; Werdich X
Am J Ophthalmol; 2014 Mar; 157(3):687-96.e1-2. PubMed ID: 24333189
[TBL] [Abstract][Full Text] [Related]
20. Perforin expression in eyelid sebaceous carcinomas: a useful and specific immunomarker for the differential diagnosis of eyelid carcinomas.
Mittal R; Araujo I; Czanner G; Coupland SE
Acta Ophthalmol; 2016 Aug; 94(5):e325-30. PubMed ID: 26843360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
